---
figid: PMC9685611__fgene-13-998220-g002
pmcid: PMC9685611
image_filename: fgene-13-998220-g002.jpg
figure_link: /pmc/articles/PMC9685611/figure/F2/
number: FIGURE 2
figure_title: ''
caption: Therapy targeted at ovarian cancer stem cells. OCSC surface markers including
  SP Cells, ALDH+ CD133+, CD44+CD24+EPCAM+E-cadherin-, CD44+/MyD88+, CD44+; underlying
  signaling pathway including Wnt/β, Notch, Hedgehog, TGF-β; immune checkpoint inhibitor
  including CTLA4,PDL1,PDL-1 inhibitors; epigenetic therapy including EMT epithelial
  to mesenchymal transition.
article_title: 'Ovarian cancer stem cells: Critical roles in anti-tumor immunity.'
citation: Jing Ding, et al. Front Genet. 2022;13:998220.
year: '2022'

doi: 10.3389/fgene.2022.998220
journal_title: Frontiers in Genetics
journal_nlm_ta: Front Genet
publisher_name: Frontiers Media S.A.

keywords:
- cancer stem cells
- ovarian cancer
- immune escape
- cancer-microenvironment
- molecular targeted therapy

---
